VRCA: Verrica Pharmaceuticals Inc. Common Stock Company Profile & Statistics

Verrica Pharmaceuticals Inc. Common Stock Profile

About

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.

Info & Links

CEO

Jayson Rieger

Headquarters

44 West Gay Street, Suite 400
WEST CHESTER, PA 19380, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

Verrica Pharmaceuticals Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

34.43M

Enterprise Value

57.18M

Enterprise Value/EBITDA(ttm)

-1.52

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

56.54%

Operating Margin(ttm)

Profit Margin(ttm)

-927.00%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-373.33%

Return on Assets(ttm)

-115.48%

Income Statement

Revenue(ttm)

14.70M

Revenue Per Share(ttm)

1.56

Gross Profit(ttm)

12.71M

EBITDA(ttm)³

-37.73M

Net Income Available to Common(ttm)

-48.60M

Diluted EPS(ttm)

-8.28

Share Statistics

Beta (5Y Monthly)

1.71

52-Week Change

-77.22%

S&P 500 52-Week Change

19.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

9.45M

Dividend Yield

0.00%

Float⁴

4.34M

% Held by Insiders

54.00%

% Held by Institutions

42.45%

Balance Sheet

Total Cash(mrq)

15.40M

Total Cash Per Share(mrq)

1.63

Total Debt(mrq)

38.15M

Total Debt/Equity(mrq)

-218.19%

Current Ratio(mrq)

1.26%

Quick Ratio(mrq)

1.17%

Book Value Per Share(mrq)

-1.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.39

Free Cash Flow(ytd)

-22.72M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

VRCA

Verrica Pharmaceuticals Inc. Common Stock